✦ LIBER ✦

Efficacy of the cognitive activation therapy (CAT) in Alzheimer's disease during six month period

✍ Scribed by Gollin, Donata; Talassi, Erica; Ferrari, Arianna; Peruzzi, Anna; Ruaro, Cristina; Codemo, Alessandra; La Sala, Angela; Poli, Sarah; Chiamenti, Andrea Maria; Gabelli, Carlo

Book ID: 123587884
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.1296

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement of functional status after c

Improvement of functional status after cognitive activation therapy (CAT) in Alzheimer's disease patients

✍ Gollin, Donata; Ferrari, Arianna; Talassi, Erika; Peruzzi, Anna; Ruaro, Cristina 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 199 KB

A 24-week, open-label extension to the A

A 24-week, open-label extension to the ACTivities of daily living and cognitION (ACTION) study: Long-term safety, tolerability and efficacy of a 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy, safety and tolerability of riv

Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: Results of the ACTivities of daily living and cognitION (ACTION) study

✍ Farlow, Martin; Meng, Xiangyi; Rensch, Scott; Somogyi, Monique 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy, safety and tolerability of riv

Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: results of the ACTivities of daily living and cognitION (ACTION) study

✍ Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 61 KB